Marché européen du syndrome de Down – Tendances et prévisions du secteur jusqu’en 2028

Personnalisez votre rapport Personnalisez votre rapport Acheter maintenantAcheter maintenant Exemple de rapport gratuitExemple de rapport gratuit
Maison Pharmaceutical Europe Down Syndrome Market
Demande de table des matières Demande de table des matières Parler à un analysteParler à un analyste Acheter maintenantAcheter maintenant Renseignez-vous avant d'acheterRenseignez-vous avant Exemple de rapport gratuitExemple de rapport gratuit

Marché européen du syndrome de Down – Tendances et prévisions du secteur jusqu’en 2028

  • Pharmaceutical
  • Publish Reports
  • Mar 2021
  • Europe
  • 350 Pages
  • Nombre de tableaux : 238
  • Nombre de figures : 18
Buy Now Acheter maintenant

>Marché européen du syndrome de Down, par type de maladie (trisomie 21, syndrome de Down par translocation, syndrome de Down en mosaïque), traitement ( diagnostic , thérapie), utilisateur final (hôpital, cliniques, soins à domicile, centres de thérapie, autres), canal de distribution (appel d'offres direct, vente au détail, autres), pays (Allemagne, Royaume-Uni, France, Italie, Espagne, Russie, Pologne, Suisse, Pays-Bas, Hongrie, Autriche, Norvège, Irlande, Turquie, Lituanie et reste de l'Europe) Tendances et prévisions de l'industrie jusqu'en 2028

Marché européen de la trisomie 21Analyse et perspectives du marché : marché européen de la trisomie 21

Le marché du syndrome de Down devrait connaître une croissance du marché au cours de la période de prévision de 2021 à 2028. Data Bridge Market Research analyse que le marché croît avec un TCAC de 13,78 % au cours de la période de prévision de 2021 à 2028 et devrait atteindre 725,12 millions USD d'ici 2028. La sensibilisation croissante à la maladie et la prévalence croissante du syndrome de Down sont les principaux moteurs qui ont propulsé la demande du marché au cours de la période de prévision.

Les progrès technologiques et le soutien croissant du gouvernement sont les principaux moteurs qui ont propulsé la demande du marché du syndrome de Down au cours de la période de prévision.

Le syndrome de Down est une maladie génétique qui se produit en raison d'une division cellulaire anormale. Cette division cellulaire anormale provoque l'apparition d'une copie supplémentaire, complète ou partielle, du chromosome 21. La présence de matériel génétique supplémentaire provoque des changements physiques et développementaux chez les personnes atteintes du syndrome de Down. L'anomalie génétique la plus courante associée au syndrome de Down comprend les troubles mentaux, principalement les troubles d'apprentissage chez les enfants.

La sensibilisation a permis à ces personnes d'opter pour de nouvelles approches diagnostiques ainsi que des thérapies avancées afin de mettre en place un mode de vie sain. Cela signifie donc que la sensibilisation croissante à la maladie agit comme un moteur de la croissance du marché du syndrome de Down . Les complications signifient que l'indisponibilité d'un traitement spécifique constitue un frein à la croissance du marché du syndrome de Down . Les acteurs du marché opérant sur le marché du syndrome de Down adoptent plusieurs initiatives stratégiques qui devraient dynamiser leurs activités dans diverses dimensions, agissant comme une opportunité pour la croissance du marché du syndrome de Down . Le long délai d'approbation associé au lancement du produit constitue un défi pour la croissance du marché du syndrome de Down .

Le rapport sur le marché du syndrome de Down fournit des détails sur la part de marché, les nouveaux développements et l'analyse du pipeline de produits, l'impact des acteurs du marché national et localisé, analyse les opportunités en termes de poches de revenus émergentes, les changements dans la réglementation du marché , les approbations de produits, les décisions stratégiques, les lancements de produits, les expansions géographiques et les innovations technologiques sur le marché. Pour comprendre l'analyse et le scénario du marché du syndrome de Down , contactez Data Bridge Market Research pour un briefing d'analyste, notre équipe vous aidera à créer une solution d'impact sur les revenus pour atteindre votre objectif souhaité.

Marché européen de la trisomie 21Portée et taille du marché du syndrome de Down

Le marché du syndrome de Down est segmenté en fonction du type de maladie, du traitement , de l'utilisateur final et du canal de distribution. La croissance entre les segments vous aide à analyser les niches de croissance et les stratégies pour aborder le marché et déterminer vos principaux domaines d'application et la différence entre vos marchés cibles.

  • En fonction du type de maladie, le marché du syndrome de Down est segmenté en trisomie 21, syndrome de Down par translocation et syndrome de Down en mosaïque. En 2021, le segment de la trisomie 21 domine le marché puisque plus de 95 % des cas de syndrome de Down sont de la trisomie 21.
  • Sur la base du traitement, le marché du syndrome de Down est segmenté en diagnostic et en thérapie. En 2021, le segment du diagnostic domine le marché car la plupart des parents effectuent des tests prénataux pour comprendre l'état du fœtus.
  • Sur la base de l'utilisateur final, le marché du syndrome de Down est segmenté en hôpitaux , cliniques, établissements de soins à domicile, centres de thérapie et autres. En 2021, le segment hospitalier domine le marché car il s'agit des principaux établissements de dépistage prénatal.
  • Sur la base du canal de distribution, le marché du syndrome de Down est segmenté en appels d'offres directs, ventes au détail et autres. En 2021, le segment des appels d'offres directs domine le marché car il constitue le principal mode d'achat de produits de diagnostic par les hôpitaux et les cliniques.

Analyse du marché du syndrome de Down au niveau des pays

Le marché du syndrome de Down est analysé et des informations sur la taille du marché sont fournies par pays, type de maladie, traitement, utilisateur final et canal de distribution comme référencé ci-dessus.

Les pays couverts dans le rapport sur le marché du syndrome de Down sont l'Allemagne, le Royaume-Uni, la France, l'Italie, l'Espagne, la Russie, la Pologne, la Suisse, les Pays-Bas, la Hongrie, l'Autriche, la Norvège, l'Irlande, la Turquie, la Lituanie et le reste de l'Europe.

L'Europe devrait connaître le taux de croissance annuel composé le plus élevé au cours de la période de prévision, car le diagnostic du syndrome de Down est un test de routine dans la plupart des pays. L'Allemagne devrait dominer le marché européen. L'Allemagne est l'un des principaux pays qui ont un énorme potentiel de marché en Europe et une demande plus élevée pour le diagnostic du syndrome de Down.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of Europe brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.

Increasing Government Support and Increasing Research and Development are Boosting the Market Growth of Down syndrome

Down syndrome market also provides you with detailed market analysis for every country growth in Down syndrome industry with Down syndrome drugs sales, impact of advancement in the Down syndrome technology and changes in regulatory scenarios with their support for the Down syndrome market. The data is available for historic period 2010 to 2019.

Competitive Landscape and Down syndrome Market Share Analysis

Down syndrome market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, production sites and facilities, company strengths and weaknesses, product launch, product trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the company’s focus related to Down syndrome market.

The major companies which are dealing in the Down syndrome are F. Hoffmann-La Roche Ltd, PerkinElmer Inc., Illumina, Inc., Thermo Fisher Scientific Inc., Myriad Genetics, Inc., Abbott, Natera, Inc, AtilaBiosystems, Physio.co.uk, Novus Biologicals (a subsidiary of Bio-Techne), Down Syndrome Cork, a branch of Down Syndrome Ireland, Demeditec Diagnostics GmbH, Symbol, ASDclinic.co.uk among other domestic players. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.

Many product launch and agreement are also initiated by the companies’ worldwide which are also accelerating the Down syndrome market.

For instance,

  • In April 2017, Illumina, Inc. launched VeriSeq NIPT solution in Europe. The product launched is a CE-IVD marked next-generation sequencing technology-based approach used for screening of chromosomal abnormalities and proved efficacious for providing accurate information about chromosomal status within 10 weeks of gestation. This product launch boosted the company’s product portfolio and allowed it to penetrate its root in worldwide Down syndrome market.

La collaboration, le lancement de produits, l'expansion commerciale, les récompenses et la reconnaissance, les coentreprises et d'autres stratégies des acteurs du marché améliorent le marché de l'entreprise sur le marché du syndrome de Down, ce qui offre également l'avantage à l'organisation d'améliorer son offre pour le syndrome de Down.

SKU-

Accédez en ligne au rapport sur le premier cloud mondial de veille économique

Sample Image Cliquez sur l'image pour l'agrandir
  • Tableau de bord d'analyse de données interactif
  • Tableau de bord d'analyse d'entreprise pour les opportunités à fort potentiel de croissance
  • Accès d'analyste de recherche pour la personnalisation et les requêtes
  • Analyse de la concurrence avec tableau de bord interactif
  • Dernières actualités, mises à jour et analyse des tendances
  • Exploitez la puissance de l'analyse comparative pour un suivi complet de la concurrence
Demande de démonstration

Table des matières

  1. introduction
    1. OBJECTIVES OF THE STUDY
    2. MARKET DEFINITION
    3. OVERVIEW of EUROPE Down syndrome MARKET
    4. LIMITATIONs
    5. MARKETS COVERED
  2. MARKET SEGMENTATION
    1. MARKETS COVERED
    2. geographical scope
    3. years considered for the study
    4. currency and pricing
    5. DBMR TRIPOD DATA VALIDATION MODEL
    6. MULTIVARIATE MODELLING
    7. treatment of Down syndrome LIFELINE CURVE
    8. primary interviews with key opinion leaders
    9. DBMR MARKET POSITION GRID
    10. MARKET END USER COVERAGE GRID
    11. vendor share analysis
    12. secondary sourcEs
    13. assumptions
  3. EXECUTIVE SUMMARY
  4. Europe DOWN SYNDROME MARKET: Pipeline analysis
    1. PIPELINE PRODUCTS IMPACT ANALYSIS
    2. NNI-351
    3. ASPARAGINASE
    4. ANVS-401
    5. QUILLIVANT XR
    6. TOFACITINIB
    7. MEMANTINE HYDROCHLORIDE
    8. NICOTINE
    9. AEF0217
    10. ACI-24
  5. Europe DOwn syndrome Market: Laws and regulations
  6. Market Overview
    1. Drivers
      1. increasing prevalence OF DOWN syndrome
      2. rising demand of effective therapies
      3. rising awareness about the diseasE
      4. technological ADVANCEMENTS
      5. increasing government support
    2. RESTRAINTS
      1. UNAVAILABILITY OF any specific treatment
      2. Side Effects Associated With Down Syndrome Treatment Therapies
      3. high cost of diagnosis
    3. opportunities
      1. STRATEGIC INITIATIVES BY MARKET PLAYERS
      2. increasing research and development
      3. presence of pipeline therapies
      4. presence of reimbursement
    4. challenGes
      1. Lack of Skilled Proffessionals
      2. Long Process for Product Launch
      3. Transfer of COVID-19 Infections by Diagnostic Methods
  7. Impact of COVID-19 on Europe Down Syndrome Market
    1. Price Impact
    2. Impact on Supply Chain
    3. Impact on Demand
    4. Strategic Decisions for Manufacturers
    5. Conclusion
  8. Europe Down syndrome MARKET, BY disease Type
    1. overview
    2. trisomy 21
    3. translocation Down syndrome
    4. mosaic Down syndrome
  9. Europe Down syndrome MARKET, BY treatment
    1. overview
    2. diagnosis
      1. Screening Tests
        1. First Trimester
          1. Blood Test
          2. Nuchal Translucency Testing
        2. Integrated Screening Test
          1. First Trimester
          2. Second Trimester
        3. The Triple Screen or Quadraple Screen Test
        4. Ultrasound
        5. Cell Free DNA
      2. Diagnostic Tests
        1. Chronic Villus Sampling
        2. Amniocentesis
        3. Precutaneous Umbical Cord Sampling
    3. therapy
      1. Early Intervention Therapy
        1. Speech-Language Therapy
        2. Physical Therapy
        3. Occupational Therapy
        4. Others
      2. Assistive Technology
        1. Hearing Aids
        2. Glasses
        3. Others
      3. Surgery
        1. Atrioventricular Septal Defect (AVSD)
        2. Duodenal Atresia
        3. Others
      4. Others
  10. Europe Down syndrome MARKET, BY end user
    1. overview
    2. hospital
    3. clinics
    4. homecare setting
    5. others
  11. Europe Down syndrome MARKET, BY distribution channel
    1. overview
    2. direct tender
    3. retail sales
    4. others
  12. EUROPE Down syndrome MARKET, by Geography
    1. europe
      1. Germany
      2. U.K.
      3. France
      4. Italy
      5. Spain
      6. Russia
      7. Poland
      8. Switzerland
      9. Netherlands
      10. Hungary
      11. Austria
      12. Norway
      13. Ireland
      14. Turkey
      15. Lithuania
      16. Rest of Europe
  13. Europe Down syndrome market: COMPANY landscape
    1. company share analysis: Europe
  14. company profile
    1. F. Hoffmann-La Roche Ltd
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. Company ANALYSIS
      4. PRODUCT PORTFOLIO
      5. RECENT DEVELOPMENTS
    2. PerkinElmer Inc.
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. COMPANY ANALYSIS
      4. PRODUCT PORTFOLIO
      5. RECENT DEVELOPMENTS
    3. Illumina, Inc.
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. COMPANY ANALYSIS
      4. PRODUCT PORTFOLIO
      5. RECENT DEVELOPMENTS
    4. Thermo Fisher Scientific Inc.
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. COMPANY ANALYSIS
      4. PRODUCT PORTFOLIO
      5. RECENT DEVELOPMENTS
    5. Myriad Genetics, Inc.
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. COMPANY ANALYSIS
      4. PRODUCT PORTFOLIO
      5. RECENT DEVELOPMENTS
    6. Abbott
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    7. Abnova Corporation
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENTS
    8. ASDclinic.co.uk
      1. COMPANY SNAPSHOT
      2. SERVICE PORTFOLIO
      3. RECENT DEVELOPMENT
    9. AtilaBiosystems
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENT
    10. Boston Children's Hospital
      1. COMPANY SNAPSHOT
      2. SERVICE PORTFOLIO
      3. RECENT DEVELOPMENTS
    11. Boys Town National Research Hospital
      1. COMPANY SNAPSHOT
      2. SERVICE PORTFOLIO
      3. RECENT DEVELOPMENTS
    12. Children's Hospital Colorado
      1. COMPANY SNAPSHOT
      2. SERVICE PORTFOLIO
      3. RECENT DEVELOPMENTS
    13. Demeditec Diagnostics GmbH
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENT
    14. Down Syndrome Cork
      1. COMPANY SNAPSHOT
      2. SERVICE PORTFOLIO
      3. RECENT DEVELOPMENTS
    15. Mayo Clinic Health System
      1. COMPANY SNAPSHOT
      2. SERVICE PORTFOLIO
      3. RECENT DEVELOPMENTS
    16. Natera, Inc.
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    17. Next Biosciences
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENTS
    18. Novus Biologicals (A Subsidiary of Bio-Techne)
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENT
    19. Kid Sense Child Development Corporation Pty Ltd
      1. COMPANY SNAPSHOT
      2. SERVICE PORTFOLIO
      3. RECENT DEVELOPMENT
    20. Physio.co.uk.
      1. COMPANY SNAPSHOT
      2. SERVICE PORTFOLIO
      3. RECENT DEVELOPMENT
    21. Symbol
      1. COMPANY SNAPSHOT
      2. SERVICE PORTFOLIO
      3. RECENT DEVELOPMENT
  15. questionnaire
  16. related reports

Liste des tableaux

TABLE 1 Europe Down syndrome market: Pipeline Analysis

TABLE 2 REGULATION imposed by several regulatory agencies in different regions

TABLE 3 Europe Down Syndrome Market, By Disease Type, 2019-2028 (USD Million)

TABLE 4 Europe Trisomy 21 in Down Syndrome Market, By Region, 2019-2028 (USD Million)

TABLE 5 Europe Translocation Down Syndrome in Down Syndrome Market, By Region, 2019-2028 (USD Million)

TABLE 6 Europe Mosaic Down Syndrome in Down Syndrome Market, By Region, 2019-2028 (USD Million)

TABLE 7 Europe Down Syndrome Market, By Treatment, 2019-2028 (USD Million)

TABLE 8 Europe Diagnosis in Down Syndrome Market, By Region, 2019-2028 (USD Million)

TABLE 9 Europe Diagnosis in Down Syndrome Market, By Treatment, 2019-2028 (USD Million)

TABLE 10 Europe Diagnosis in Down Syndrome Market, By Treatment, 2019-2028 (USD Million)

TABLE 11 Europe First Trimester in Down Syndrome Market, By Treatment, 2019-2028 (USD Million)

TABLE 12 Europe Integrated Screening Test in Diagnosis in Down Syndrome Market, By Treatment, 2019-2028 (USD Million)

TABLE 13 Europe Diagnostic Tests in Down Syndrome Market, By Treatment, 2019-2028 (USD Million)

TABLE 14 Europe Therapy in Down Syndrome Market, By Region, 2019-2028 (USD Million)

TABLE 15 Europe Therapy in Down Syndrome Market, By Treatment, 2019-2028 (USD Million)

TABLE 16 Europe Early Intervention Therapy in Down Syndrome Market, By Treatment, 2019-2028 (USD Million)

TABLE 17 Europe Assistive Technology in Down Syndrome Market, By Treatment, 2019-2028 (USD Million)

TABLE 18 Europe Surgery in Down Syndrome Market, By Treatment, 2019-2028 (USD Million)

TABLE 19 Europe Therapy in Down Syndrom Market, By End User, 2019-2028 (USD Million)

TABLE 20 Europe Hospital in Down Syndrome Market, By Region, 2019-2028 (USD Million)

TABLE 21 Europe Clinics in Down Syndrome Market, By Region, 2019-2028 (USD Million)

TABLE 22 Europe Homecare Setting in Down Syndrome Market, By Region, 2019-2028 (USD Million)

TABLE 23 Europe Therapy Centers in Down Syndrome Market, By Region, 2019-2028 (USD Million)

TABLE 24 Europe Others in Down Syndrome Market, By Region, 2019-2028 (USD Million)

TABLE 25 Europe Down Syndrome Market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 26 Europe Direct Tender in Down Syndrome Market, By Region, 2019-2028 (USD Million)

TABLE 27 Europe Retail Sales in Down Syndrome Market, By Region, 2019-2028 (USD Million)

TABLE 28 Europe Others in Down Syndrome Market, By Region, 2019-2028 (USD Million)

TABLE 29 europe Down syndrome Market, By Country, 2019-2028 (USD Million)

TABLE 30 europe Down SYNDROME MARKET, By disease type, 2019-2028 (USD Million)

TABLE 31 europe Down SYNDROME MARKET, By treatment, 2019-2028 (USD Million)

TABLE 32 europe diagnosis in Down SYNDROME MARKET, By Treatment, 2019-2028 (USD Million)

TABLE 33 europe screening tests in Down syndrome Market, By Treatment, 2019-2028 (USD Million)

TABLE 34 europe first trimester in Down syndrome Market, By Treatment, 2019-2028 (USD Million)

TABLE 35 europe integrated screening tests in Down syndrome Market, By Treatment, 2019-2028 (USD Million)

TABLE 36 europe diagnostic tests in Down syndrome Market, By Treatment, 2019-2028 (USD Million)

TABLE 37 europe therapy in Down syndrome Market, By treatment, 2019-2028 (USD Million)

TABLE 38 europe early intervention therapy in Down syndrome Market, By treatment, 2019-2028 (USD Million)

TABLE 39 europe assistive technology in Down syndrome Market, By treatment, 2019-2028 (USD Million)

TABLE 40 europe surgery in Down SYNDROME MARKET, By treatment, 2019-2028 (USD Million)

TABLE 41 europe Down syndrome Market, By End User, 2019-2028 (USD Million)

TABLE 42 europe Down SYNDROME MARKET, By Distribution Channel, 2019-2028 (USD Million)

TABLE 43 germany Down SYNDROME MARKET, By disease type, 2019-2028 (USD Million)

TABLE 44 germany Down SYNDROME MARKET, By treatment, 2019-2028 (USD Million)

TABLE 45 germany diagnosis in Down SYNDROME MARKET, By Treatment, 2019-2028 (USD Million)

TABLE 46 germany screening tests in Down syndrome Market, By Treatment, 2019-2028 (USD Million)

TABLE 47 germany first trimester in Down syndrome Market, By Treatment, 2019-2028 (USD Million)

TABLE 48 germany integrated screening tests in Down syndrome Market, By Treatment, 2019-2028 (USD Million)

TABLE 49 germany diagnostic tests in Down syndrome Market, By Treatment, 2019-2028 (USD Million)

TABLE 50 germany therapy in Down syndrome Market, By treatment, 2019-2028 (USD Million)

TABLE 51 germany early intervention therapy in Down syndrome Market, By treatment, 2019-2028 (USD Million)

TABLE 52 germany assistive technology in Down syndrome Market, By treatment, 2019-2028 (USD Million)

TABLE 53 germany surgery in Down SYNDROME MARKET, By treatment, 2019-2028 (USD Million)

TABLE 54 germany Down syndrome Market, By End User, 2019-2028 (USD Million)

TABLE 55 germany Down SYNDROME MARKET, By Distribution Channel, 2019-2028 (USD Million)

TABLE 56 U.K. Down SYNDROME MARKET, By disease type, 2019-2028 (USD Million)

TABLE 57 U.K. Down SYNDROME MARKET, By treatment, 2019-2028 (USD Million)

TABLE 58 U.K. diagnosis in Down SYNDROME MARKET, By Treatment, 2019-2028 (USD Million)

TABLE 59 U.K. screening tests in Down syndrome Market, By Treatment, 2019-2028 (USD Million)

TABLE 60 U.K. first trimester in Down syndrome Market, By Treatment, 2019-2028 (USD Million)

TABLE 61 U.K. integrated screening tests in Down syndrome Market, By Treatment, 2019-2028 (USD Million)

TABLE 62 U.K. diagnostic tests in Down syndrome Market, By Treatment, 2019-2028 (USD Million)

TABLE 63 U.K. therapy in Down syndrome Market, By treatment, 2019-2028 (USD Million)

TABLE 64 U.K. early intervention therapy in Down syndrome Market, By treatment, 2019-2028 (USD Million)

TABLE 65 U.K. assistive technology in Down syndrome Market, By treatment, 2019-2028 (USD Million)

TABLE 66 U.K. surgery in Down SYNDROME MARKET, By treatment, 2019-2028 (USD Million)

TABLE 67 U.K. Down syndrome Market, By End User, 2019-2028 (USD Million)

TABLE 68 U.K. Down SYNDROME MARKET, By Distribution Channel, 2019-2028 (USD Million)

TABLE 69 france Down SYNDROME MARKET, By disease type, 2019-2028 (USD Million)

TABLE 70 france Down SYNDROME MARKET, By treatment, 2019-2028 (USD Million)

TABLE 71 france diagnosis in Down SYNDROME MARKET, By Treatment, 2019-2028 (USD Million)

TABLE 72 france screening tests in Down syndrome Market, By Treatment, 2019-2028 (USD Million)

TABLE 73 france first trimester in Down syndrome Market, By Treatment, 2019-2028 (USD Million)

TABLE 74 france integrated screening tests in Down syndrome Market, By Treatment, 2019-2028 (USD Million)

TABLE 75 france diagnostic tests in Down syndrome Market, By Treatment, 2019-2028 (USD Million)

TABLE 76 france therapy in Down syndrome Market, By treatment, 2019-2028 (USD Million)

TABLE 77 france early intervention therapy in Down syndrome Market, By treatment, 2019-2028 (USD Million)

TABLE 78 france assistive technology in Down syndrome Market, By treatment, 2019-2028 (USD Million)

TABLE 79 france surgery in Down SYNDROME MARKET, By treatment, 2019-2028 (USD Million)

TABLE 80 france Down syndrome Market, By End User, 2019-2028 (USD Million)

TABLE 81 france Down SYNDROME MARKET, By Distribution Channel, 2019-2028 (USD Million)

TABLE 82 italy Down SYNDROME MARKET, By disease type, 2019-2028 (USD Million)

TABLE 83 italy Down SYNDROME MARKET, By treatment, 2019-2028 (USD Million)

TABLE 84 italy diagnosis in Down SYNDROME MARKET, By Treatment, 2019-2028 (USD Million)

TABLE 85 italy screening tests in Down syndrome Market, By Treatment, 2019-2028 (USD Million)

TABLE 86 italy first trimester in Down syndrome Market, By Treatment, 2019-2028 (USD Million)

TABLE 87 italy integrated screening tests in Down syndrome Market, By Treatment, 2019-2028 (USD Million)

TABLE 88 italy diagnostic tests in Down syndrome Market, By Treatment, 2019-2028 (USD Million)

TABLE 89 italy therapy in Down syndrome Market, By treatment, 2019-2028 (USD Million)

TABLE 90 italy early intervention therapy in Down syndrome Market, By treatment, 2019-2028 (USD Million)

TABLE 91 italy assistive technology in Down syndrome Market, By treatment, 2019-2028 (USD Million)

TABLE 92 italy surgery in Down SYNDROME MARKET, By treatment, 2019-2028 (USD Million)

TABLE 93 italy Down syndrome Market, By End User, 2019-2028 (USD Million)

TABLE 94 italy Down SYNDROME MARKET, By Distribution Channel, 2019-2028 (USD Million)

TABLE 95 spain Down SYNDROME MARKET, By disease type, 2019-2028 (USD Million)

TABLE 96 spain Down SYNDROME MARKET, By treatment, 2019-2028 (USD Million)

TABLE 97 spain diagnosis in Down SYNDROME MARKET, By Treatment, 2019-2028 (USD Million)

TABLE 98 spain screening tests in Down syndrome Market, By Treatment, 2019-2028 (USD Million)

TABLE 99 spain first trimester in Down syndrome Market, By Treatment, 2019-2028 (USD Million)

TABLE 100 spain integrated screening tests in Down syndrome Market, By Treatment, 2019-2028 (USD Million)

TABLE 101 spain diagnostic tests in Down syndrome Market, By Treatment, 2019-2028 (USD Million)

TABLE 102 spain therapy in Down syndrome Market, By treatment, 2019-2028 (USD Million)

TABLE 103 spain early intervention therapy in Down syndrome Market, By treatment, 2019-2028 (USD Million)

TABLE 104 spain assistive technology in Down syndrome Market, By treatment, 2019-2028 (USD Million)

TABLE 105 spain surgery in Down SYNDROME MARKET, By treatment, 2019-2028 (USD Million)

TABLE 106 spain Down syndrome Market, By End User, 2019-2028 (USD Million)

TABLE 107 spain Down SYNDROME MARKET, By Distribution Channel, 2019-2028 (USD Million)

TABLE 108 russia Down SYNDROME MARKET, By disease type, 2019-2028 (USD Million)

TABLE 109 russia Down SYNDROME MARKET, By treatment, 2019-2028 (USD Million)

TABLE 110 russia diagnosis in Down SYNDROME MARKET, By Treatment, 2019-2028 (USD Million)

TABLE 111 russia screening tests in Down syndrome Market, By Treatment, 2019-2028 (USD Million)

TABLE 112 russia first trimester in Down syndrome Market, By Treatment, 2019-2028 (USD Million)

TABLE 113 russia integrated screening tests in Down syndrome Market, By Treatment, 2019-2028 (USD Million)

TABLE 114 russia diagnostic tests in Down syndrome Market, By Treatment, 2019-2028 (USD Million)

TABLE 115 russia therapy in Down syndrome Market, By treatment, 2019-2028 (USD Million)

TABLE 116 russia early intervention therapy in Down syndrome Market, By treatment, 2019-2028 (USD Million)

TABLE 117 russia assistive technology in Down syndrome Market, By treatment, 2019-2028 (USD Million)

TABLE 118 russia surgery in Down SYNDROME MARKET, By treatment, 2019-2028 (USD Million)

TABLE 119 russia Down syndrome Market, By End User, 2019-2028 (USD Million)

TABLE 120 russia Down SYNDROME MARKET, By Distribution Channel, 2019-2028 (USD Million)

TABLE 121 poland Down SYNDROME MARKET, By disease type, 2019-2028 (USD Million)

TABLE 122 poland Down SYNDROME MARKET, By treatment, 2019-2028 (USD Million)

TABLE 123 poland diagnosis in Down SYNDROME MARKET, By Treatment, 2019-2028 (USD Million)

TABLE 124 poland screening tests in Down syndrome Market, By Treatment, 2019-2028 (USD Million)

TABLE 125 poland first trimester in Down syndrome Market, By Treatment, 2019-2028 (USD Million)

TABLE 126 poland integrated screening tests in Down syndrome Market, By Treatment, 2019-2028 (USD Million)

TABLE 127 poland diagnostic tests in Down syndrome Market, By Treatment, 2019-2028 (USD Million)

TABLE 128 poland therapy in Down syndrome Market, By treatment, 2019-2028 (USD Million)

TABLE 129 poland early intervention therapy in Down syndrome Market, By treatment, 2019-2028 (USD Million)

TABLE 130 poland assistive technology in Down syndrome Market, By treatment, 2019-2028 (USD Million)

TABLE 131 poland surgery in Down SYNDROME MARKET, By treatment, 2019-2028 (USD Million)

TABLE 132 poland Down syndrome Market, By End User, 2019-2028 (USD Million)

TABLE 133 poland Down SYNDROME MARKET, By Distribution Channel, 2019-2028 (USD Million)

TABLE 134 switzerland Down SYNDROME MARKET, By disease type, 2019-2028 (USD Million)

TABLE 135 switzerland Down SYNDROME MARKET, By treatment, 2019-2028 (USD Million)

TABLE 136 switzerland diagnosis in Down SYNDROME MARKET, By Treatment, 2019-2028 (USD Million)

TABLE 137 switzerland screening tests in Down syndrome Market, By Treatment, 2019-2028 (USD Million)

TABLE 138 switzerland first trimester in Down syndrome Market, By Treatment, 2019-2028 (USD Million)

TABLE 139 switzerland integrated screening tests in Down syndrome Market, By Treatment, 2019-2028 (USD Million)

TABLE 140 switzerland diagnostic tests in Down syndrome Market, By Treatment, 2019-2028 (USD Million)

TABLE 141 switzerland therapy in Down syndrome Market, By treatment, 2019-2028 (USD Million)

TABLE 142 switzerland early intervention therapy in Down syndrome Market, By treatment, 2019-2028 (USD Million)

TABLE 143 switzerland assistive technology in Down syndrome Market, By treatment, 2019-2028 (USD Million)

TABLE 144 switzerland surgery in Down SYNDROME MARKET, By treatment, 2019-2028 (USD Million)

TABLE 145 switzerland Down syndrome Market, By End User, 2019-2028 (USD Million)

TABLE 146 switzerland Down SYNDROME MARKET, By Distribution Channel, 2019-2028 (USD Million)

TABLE 147 netherlands Down SYNDROME MARKET, By disease type, 2019-2028 (USD Million)

TABLE 148 netherlands Down SYNDROME MARKET, By treatment, 2019-2028 (USD Million)

TABLE 149 netherlands diagnosis in Down SYNDROME MARKET, By Treatment, 2019-2028 (USD Million)

TABLE 150 netherlands screening tests in Down syndrome Market, By Treatment, 2019-2028 (USD Million)

TABLE 151 netherlands first trimester in Down syndrome Market, By Treatment, 2019-2028 (USD Million)

TABLE 152 netherlands integrated screening tests in Down syndrome Market, By Treatment, 2019-2028 (USD Million)

TABLE 153 netherlands diagnostic tests in Down syndrome Market, By Treatment, 2019-2028 (USD Million)

TABLE 154 netherlands therapy in Down syndrome Market, By treatment, 2019-2028 (USD Million)

TABLE 155 netherlands early intervention therapy in Down syndrome Market, By treatment, 2019-2028 (USD Million)

TABLE 156 netherlands assistive technology in Down syndrome Market, By treatment, 2019-2028 (USD Million)

TABLE 157 netherlands surgery in Down SYNDROME MARKET, By treatment, 2019-2028 (USD Million)

TABLE 158 netherlands Down syndrome Market, By End User, 2019-2028 (USD Million)

TABLE 159 netherlands Down SYNDROME MARKET, By Distribution Channel, 2019-2028 (USD Million)

TABLE 160 hungary Down SYNDROME MARKET, By disease type, 2019-2028 (USD Million)

TABLE 161 hungary Down SYNDROME MARKET, By treatment, 2019-2028 (USD Million)

TABLE 162 hungary diagnosis in Down SYNDROME MARKET, By Treatment, 2019-2028 (USD Million)

TABLE 163 hungary screening tests in Down syndrome Market, By Treatment, 2019-2028 (USD Million)

TABLE 164 hungary first trimester in Down syndrome Market, By Treatment, 2019-2028 (USD Million)

TABLE 165 hungary integrated screening tests in Down syndrome Market, By Treatment, 2019-2028 (USD Million)

TABLE 166 hungary diagnostic tests in Down syndrome Market, By Treatment, 2019-2028 (USD Million)

TABLE 167 hungary therapy in Down syndrome Market, By treatment, 2019-2028 (USD Million)

TABLE 168 hungary early intervention therapy in Down syndrome Market, By treatment, 2019-2028 (USD Million)

TABLE 169 hungary assistive technology in Down syndrome Market, By treatment, 2019-2028 (USD Million)

TABLE 170 hungary surgery in Down SYNDROME MARKET, By treatment, 2019-2028 (USD Million)

TABLE 171 hungary Down syndrome Market, By End User, 2019-2028 (USD Million)

TABLE 172 hungary Down SYNDROME MARKET, By Distribution Channel, 2019-2028 (USD Million)

TABLE 173 austria Down SYNDROME MARKET, By disease type, 2019-2028 (USD Million)

TABLE 174 austria Down SYNDROME MARKET, By treatment, 2019-2028 (USD Million)

TABLE 175 austria diagnosis in Down SYNDROME MARKET, By Treatment, 2019-2028 (USD Million)

TABLE 176 austria screening tests in Down syndrome Market, By Treatment, 2019-2028 (USD Million)

TABLE 177 austria first trimester in Down syndrome Market, By Treatment, 2019-2028 (USD Million)

TABLE 178 austria integrated screening tests in Down syndrome Market, By Treatment, 2019-2028 (USD Million)

TABLE 179 austria diagnostic tests in Down syndrome Market, By Treatment, 2019-2028 (USD Million)

TABLE 180 austria therapy in Down syndrome Market, By treatment, 2019-2028 (USD Million)

TABLE 181 austria early intervention therapy in Down syndrome Market, By treatment, 2019-2028 (USD Million)

TABLE 182 austria assistive technology in Down syndrome Market, By treatment, 2019-2028 (USD Million)

TABLE 183 austria surgery in Down SYNDROME MARKET, By treatment, 2019-2028 (USD Million)

TABLE 184 austria Down syndrome Market, By End User, 2019-2028 (USD Million)

TABLE 185 austria Down SYNDROME MARKET, By Distribution Channel, 2019-2028 (USD Million)

TABLE 186 norway Down SYNDROME MARKET, By disease type, 2019-2028 (USD Million)

TABLE 187 norway Down SYNDROME MARKET, By treatment, 2019-2028 (USD Million)

TABLE 188 norway diagnosis in Down SYNDROME MARKET, By Treatment, 2019-2028 (USD Million)

TABLE 189 norway screening tests in Down syndrome Market, By Treatment, 2019-2028 (USD Million)

TABLE 190 norway first trimester in Down syndrome Market, By Treatment, 2019-2028 (USD Million)

TABLE 191 norway integrated screening tests in Down syndrome Market, By Treatment, 2019-2028 (USD Million)

TABLE 192 norway diagnostic tests in Down syndrome Market, By Treatment, 2019-2028 (USD Million)

TABLE 193 norway therapy in Down syndrome Market, By treatment, 2019-2028 (USD Million)

TABLE 194 norway early intervention therapy in Down syndrome Market, By treatment, 2019-2028 (USD Million)

TABLE 195 norway assistive technology in Down syndrome Market, By treatment, 2019-2028 (USD Million)

TABLE 196 norway surgery in Down SYNDROME MARKET, By treatment, 2019-2028 (USD Million)

TABLE 197 norway Down syndrome Market, By End User, 2019-2028 (USD Million)

TABLE 198 norway Down SYNDROME MARKET, By Distribution Channel, 2019-2028 (USD Million)

TABLE 199 ireland Down SYNDROME MARKET, By disease type, 2019-2028 (USD Million)

TABLE 200 ireland Down SYNDROME MARKET, By treatment, 2019-2028 (USD Million)

TABLE 201 ireland diagnosis in Down SYNDROME MARKET, By Treatment, 2019-2028 (USD Million)

TABLE 202 ireland screening tests in Down syndrome Market, By Treatment, 2019-2028 (USD Million)

TABLE 203 ireland first trimester in Down syndrome Market, By Treatment, 2019-2028 (USD Million)

TABLE 204 ireland integrated screening tests in Down syndrome Market, By Treatment, 2019-2028 (USD Million)

TABLE 205 ireland diagnostic tests in Down syndrome Market, By Treatment, 2019-2028 (USD Million)

TABLE 206 ireland therapy in Down syndrome Market, By treatment, 2019-2028 (USD Million)

TABLE 207 ireland early intervention therapy in Down syndrome Market, By treatment, 2019-2028 (USD Million)

TABLE 208 ireland assistive technology in Down syndrome Market, By treatment, 2019-2028 (USD Million)

TABLE 209 ireland surgery in Down SYNDROME MARKET, By treatment, 2019-2028 (USD Million)

TABLE 210 ireland Down syndrome Market, By End User, 2019-2028 (USD Million)

TABLE 211 ireland Down SYNDROME MARKET, By Distribution Channel, 2019-2028 (USD Million)

TABLE 212 turkey Down SYNDROME MARKET, By disease type, 2019-2028 (USD Million)

TABLE 213 turkey Down SYNDROME MARKET, By treatment, 2019-2028 (USD Million)

TABLE 214 turkey diagnosis in Down SYNDROME MARKET, By Treatment, 2019-2028 (USD Million)

TABLE 215 turkey screening tests in Down syndrome Market, By Treatment, 2019-2028 (USD Million)

TABLE 216 turkey first trimester in Down syndrome Market, By Treatment, 2019-2028 (USD Million)

TABLE 217 turkey integrated screening tests in Down syndrome Market, By Treatment, 2019-2028 (USD Million)

TABLE 218 turkey diagnostic tests in Down syndrome Market, By Treatment, 2019-2028 (USD Million)

TABLE 219 turkey therapy in Down syndrome Market, By treatment, 2019-2028 (USD Million)

TABLE 220 turkey early intervention therapy in Down syndrome Market, By treatment, 2019-2028 (USD Million)

TABLE 221 turkey assistive technology in Down syndrome Market, By treatment, 2019-2028 (USD Million)

TABLE 222 turkey surgery in Down SYNDROME MARKET, By treatment, 2019-2028 (USD Million)

TABLE 223 turkey Down syndrome Market, By End User, 2019-2028 (USD Million)

TABLE 224 turkey Down SYNDROME MARKET, By Distribution Channel, 2019-2028 (USD Million)

TABLE 225 lithuania Down SYNDROME MARKET, By disease type, 2019-2028 (USD Million)

TABLE 226 lithuania Down SYNDROME MARKET, By treatment, 2019-2028 (USD Million)

TABLE 227 lithuania diagnosis in Down SYNDROME MARKET, By Treatment, 2019-2028 (USD Million)

TABLE 228 lithuania screening tests in Down syndrome Market, By Treatment, 2019-2028 (USD Million)

TABLE 229 lithuania first trimester in Down syndrome Market, By Treatment, 2019-2028 (USD Million)

TABLE 230 lithuania integrated screening tests in Down syndrome Market, By Treatment, 2019-2028 (USD Million)

TABLE 231 lithuania diagnostic tests in Down syndrome Market, By Treatment, 2019-2028 (USD Million)

TABLE 232 lithuania therapy in Down syndrome Market, By treatment, 2019-2028 (USD Million)

TABLE 233 lithuania early intervention therapy in Down syndrome Market, By treatment, 2019-2028 (USD Million)

TABLE 234 lithuania assistive technology in Down syndrome Market, By treatment, 2019-2028 (USD Million)

TABLE 235 lithuania surgery in Down SYNDROME MARKET, By treatment, 2019-2028 (USD Million)

TABLE 236 lithuania Down syndrome Market, By End User, 2019-2028 (USD Million)

TABLE 237 lithuania Down SYNDROME MARKET, By Distribution Channel, 2019-2028 (USD Million)

TABLE 238 rest of europe Down SYNDROME MARKET, By disease type, 2019-2028 (USD Million)

Liste des figures

FIGURE 1 Europe DOWN SYNDROME MARKET: SEGMENTATION

FIGURE 2 EUROPE DOWN SYNDROME MARKET : DATA TRIANGULATION

FIGURE 3 Europe Down syndrome Market: DROC ANALYSIS

FIGURE 4 Europe Down syndrome market: Europe VS. REGIONAL MARKET ANALYSIS

FIGURE 5 Europe Down syndrome Market: COMPANY RESEARCH ANALYSIS

FIGURE 6 EUROPE Down syndrome MARKET: MULTIVARIATE MODELLING

FIGURE 7 EUROPE Down syndrome MARKET: INTERVIEW DEMOGRAPHICS

FIGURE 8 EUROPE DOWN SYNDROME MARKET: DBMR MARKET POSITION GRID

FIGURE 9 EUROPE down syndrome Market: MARKET END UsER COVERAGE GRID

FIGURE 10 EUROPE DOWN SYNDROME MARKET: VENDOR SHARE ANALYSIS

FIGURE 11 Europe Down syndrome market: SEGMENTATION

FIGURE 12 Increasing PREVALENCE of Down syndrome and Other Related Disorders and Rising Demand for Effective therapies is DRIVing THE Europe Down syndrome MARKET IN THE FORECAST PERIOD OF 2021 to 2028

FIGURE 13 trisomy 21 SEGMENT is expected to account for the largest share of the Europe DOWN SYNDROME MARKET in 2021 & 2028

FIGURE 14 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGEs OF EUROPE Down syndrome market

FIGURE 15 Europe Down syndrome market: BY disease type, 2020

FIGURE 16 Europe Down syndrome market: BY disease type, 2020-2028 (USD Million)

FIGURE 17 Europe Down syndrome market: BY disease type, CAGR (2020-2028)

FIGURE 18 Europe Down syndrome market: BY disease type, LIFELINE CURVE

FIGURE 1 Europe Down syndrome market: BY treatment, 2020

FIGURE 2 Europe Down syndrome market: BY treatment, 2020-2028 (USD Million).

FIGURE 3 Europe Down syndrome market: BY treatment, CAGR (2020-2028)

FIGURE 4 Europe Down syndrome market: BY treatment, LIFELINE CURVE

FIGURE 5 Europe Down syndrome market: BY end user, 2020

FIGURE 6 Europe Down syndrome market: BY end user, 2020-2028 (USD Million)

FIGURE 7 Europe Down syndrome market: BY end user, CAGR (2020-2028)

FIGURE 8 Europe Down syndrome market: BY end user, LIFELINE CURVE

FIGURE 9 Europe Down syndrome market: BY distribution channel, 2020

FIGURE 10 Europe Down syndrome market: BY distribution channel, 2020-2028 (USD Million)

FIGURE 11 Europe Down syndrome market: BY distribution channel, CAGR (2020-2028)

FIGURE 12 Europe Down syndrome market: BY distribution channel, LIFELINE CURVE

FIGURE 13 europe Down syndrome market: SNAPSHOT (2020)

FIGURE 14 europe Down syndrome market: BY COUNTRY (2020)

FIGURE 15 europe Down syndrome market: BY COUNTRY (2021 & 2028)

FIGURE 16 europe Down syndrome market: BY COUNTRY (2021 & 2028)

FIGURE 17 europe Down syndrome market: BY treatment (2021-2028)

FIGURE 18 Europe Down syndrome market: company share 2020 (%)

Voir les informations détaillées Right Arrow

Méthodologie de recherche

La collecte de données et l'analyse de l'année de base sont effectuées à l'aide de modules de collecte de données avec des échantillons de grande taille. L'étape consiste à obtenir des informations sur le marché ou des données connexes via diverses sources et stratégies. Elle comprend l'examen et la planification à l'avance de toutes les données acquises dans le passé. Elle englobe également l'examen des incohérences d'informations observées dans différentes sources d'informations. Les données de marché sont analysées et estimées à l'aide de modèles statistiques et cohérents de marché. De plus, l'analyse des parts de marché et l'analyse des tendances clés sont les principaux facteurs de succès du rapport de marché. Pour en savoir plus, veuillez demander un appel d'analyste ou déposer votre demande.

La méthodologie de recherche clé utilisée par l'équipe de recherche DBMR est la triangulation des données qui implique l'exploration de données, l'analyse de l'impact des variables de données sur le marché et la validation primaire (expert du secteur). Les modèles de données incluent la grille de positionnement des fournisseurs, l'analyse de la chronologie du marché, l'aperçu et le guide du marché, la grille de positionnement des entreprises, l'analyse des brevets, l'analyse des prix, l'analyse des parts de marché des entreprises, les normes de mesure, l'analyse globale par rapport à l'analyse régionale et des parts des fournisseurs. Pour en savoir plus sur la méthodologie de recherche, envoyez une demande pour parler à nos experts du secteur.

Personnalisation disponible

Data Bridge Market Research est un leader de la recherche formative avancée. Nous sommes fiers de fournir à nos clients existants et nouveaux des données et des analyses qui correspondent à leurs objectifs. Le rapport peut être personnalisé pour inclure une analyse des tendances des prix des marques cibles, une compréhension du marché pour d'autres pays (demandez la liste des pays), des données sur les résultats des essais cliniques, une revue de la littérature, une analyse du marché des produits remis à neuf et de la base de produits. L'analyse du marché des concurrents cibles peut être analysée à partir d'une analyse basée sur la technologie jusqu'à des stratégies de portefeuille de marché. Nous pouvons ajouter autant de concurrents que vous le souhaitez, dans le format et le style de données que vous recherchez. Notre équipe d'analystes peut également vous fournir des données sous forme de fichiers Excel bruts, de tableaux croisés dynamiques (Fact book) ou peut vous aider à créer des présentations à partir des ensembles de données disponibles dans le rapport.

Parcourir les pages associées

Banner